DBT
MRVI icon

Dubuque Bank & Trust’s Maravai LifeSciences MRVI Stock Holding History

Dubuque Bank & Trust’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,680
Closed -$279K – 276
2021
Q3 		$279K Buy
+5,680
New +$277K 0.03% 212

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Dubuque Bank & Trust's MRVI Position: Q4 2021 in Review

Dubuque Bank & Trust sold out of Maravai LifeSciences (MRVI) in Q4 2021, closing a stake of 5,680 shares — an estimated $279K sold.

Dubuque Bank & Trust first reported a position in MRVI in Q3 2021 and held it in 1 quarter. The position peaked at $279K in Q3 2021. 229 funds tracked by Wall St. Rank hold MRVI as of Q4 2021.

  • Dubuque Bank & Trust reported no remaining Maravai LifeSciences position as of Q4 2021 after selling out during the quarter.
  • Dubuque Bank & Trust sold 5,680 Maravai LifeSciences shares in Q4 2021, an estimated $279K.
  • Dubuque Bank & Trust first reported a position in Maravai LifeSciences in Q3 2021 and held it in 1 quarter.
  • Dubuque Bank & Trust's Maravai LifeSciences position peaked at $279K in Q3 2021.
  • 229 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2021.

Based on Dubuque Bank & Trust's 13F filing for Q4 2021, filed 28 Jan 2022.